National Cancer Plan

Freddie van Mierlo Excerpts

Tuesday 4th February 2025 Commons Chamber

[Andrew Gwynne]

I cannot even begin to think what it would be like to lose a child full stop, but to lose them to cancer would be horrific for their parents. I pay tribute to Lorraine for all the campaigning she has done on this. I am more than happy to meet my hon. Friend and Lorraine to talk about this, but the whole reason for putting the taskforce back on an operational footing is so that we can make the changes that she and Lorraine want to see.

[Freddie van Mierlo (Henley and Thame) (LD)]

Members across the House will be all too familiar with constituents reaching out to let them know that safe, effective new medicines are not approved by the National Institute for Health and Care Excellence. The Minister speaks of research and the need for access. Will he commit to being a critical friend of NICE, to ensure both good value for the taxpayer and good access for patients?

[Andrew Gwynne]

The hon. Gentleman makes a good point. NICE is there for a particular reason: to ensure that the drugs being developed are available on the NHS when they meet the required threshold. Of course, we want to ensure that as new treatments become available, they are available for British patients. The work that is being done with Moderna and other pharmaceutical companies will ensure that British patients have access to some of the latest treatments as they come through the pipeline.